Cancer Treatment Products:including targeted therapies, immunotherapies, antibody‑drug conjugates (ADCs), cell and gene therapies, chemotherapy agents, and other innovative anticancer drugs—both those already on the market and those currently under development.

Diagnostic and Testing Technologies:liquid biopsies, companion diagnostics, molecular subtyping, AI‑assisted diagnosis, and biomarker detection platforms.

‌Medical Devices and Equipment:radiation therapy equipment such as proton therapy systems and image‑guided delivery platforms, surgical robots, and supportive care devices.

‌Clinical Research Services and Platforms:CRO/CDMO firms, electronic data capture systems, clinical trial management software, and patient recruitment solutions.

Digital Health and AI Tools:oncology decision‑support systems, remote follow‑up platforms, and patient‑management apps.

Academic Publishing and Educational Services:medical publishing houses, continuing education programs, and oncology guidelines and databases (such as ASCO University and the JCO platform).

Patient Support Organizations and Public‑Interest Initiatives:cancer advocacy groups, survivor‑care resources, and initiatives addressing affordability and access.